BiotechTube

tramadol hydrochloride + acetaminophen

ApprovedCompleted
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Surgery, Oral

Conditions

Surgery, Oral, Pain, Postoperative

Trial Timeline

Nov 1, 2002 → Feb 1, 2003

NCT ID
NCT00236483

About tramadol hydrochloride + acetaminophen

tramadol hydrochloride + acetaminophen is a approved stage product being developed by Johnson & Johnson for Surgery, Oral. The current trial status is completed. This product is registered under clinical trial identifier NCT00236483. Target conditions include Surgery, Oral, Pain, Postoperative.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (2)

NCT IDPhaseStatus
NCT00766675ApprovedCompleted
NCT00236483ApprovedCompleted

Competing Products

20 competing products in Surgery, Oral

See all competitors
ProductCompanyStageHype Score
Ilofotase alfa + PlaceboAM-PharmaPhase 2
44
Popliteal nerve block including liposomal bupivacaine + Adductor canal nerve block including liposomal bupivacaine + Continuous popliteal nerve block with normal saline + Popliteal nerve block with exclusively unencapsulated bupivacaine + Adductor canal nerve block with exclusively unencapsulated bupivacaine + Continuous popliteal nerve block with unencapsulated bupivacainePacira BiosciencesApproved
80
DuloxetineEli LillyPhase 3
77
Pudexacianinium chlorideAstellas PharmaPhase 2
52
ISV-305Sun PharmaceuticalPhase 3
77
ISV-305Sun PharmaceuticalPhase 3
77
DE-108 + Levofloxacin 0.5%Santen PharmaceuticalPhase 3
77
SHR0410 Injection + SHR0410 Injection + PlaceboJiangsu Hengrui MedicinePhase 3
77
HR021618 + PlaceboJiangsu Hengrui MedicinePhase 2
52
Remimazolam Tosilate + PropofolJiangsu Hengrui MedicinePhase 3
77
Herombopag tablets + Herombopag placebo tabletsJiangsu Hengrui MedicinePhase 3
77
Omaveloxolone Ophthalmic Suspension 1.0% + Omaveloxolone Opthalmic Suspension 0.5% + PlaceboAbbViePhase 2
52
Placebo + ABT-719AbbViePhase 2
52
EsomeprazoleAstraZenecaApproved
85
Andexanet alfa + Usual CareAstraZenecaPhase 3
77
Sugammadex + Neostigmine + Glycopyrrolate + RocuroniumMerckApproved
85
Rocuronium + RocuroniumMerckApproved
85
SugammadexMerckApproved
85
etoricoxib 120 mgMerckApproved
85
Sugammadex + PlaceboMerckApproved
85

Other Products from Johnson & Johnson

Fentanyl transdermal therapeutic systemApproved
85
Nicotine Gum + Nicotine PatchApproved
85
galantamineApproved
85
IbrutinibApproved
85
Paliperidone ERApproved
85